nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—attention deficit hyperactivity disorder—Clonidine—glaucoma	0.401	1	CpDpCtD
Nortriptyline—CHRM3—Carbachol—glaucoma	0.0321	0.075	CbGbCtD
Nortriptyline—CHRM3—Pilocarpine—glaucoma	0.0298	0.0697	CbGbCtD
Nortriptyline—ADRA1A—Apraclonidine—glaucoma	0.0296	0.0691	CbGbCtD
Nortriptyline—CHRM1—Carbachol—glaucoma	0.0279	0.0652	CbGbCtD
Nortriptyline—CHRM1—Pilocarpine—glaucoma	0.0259	0.0607	CbGbCtD
Nortriptyline—CHRM2—Carbachol—glaucoma	0.0257	0.0602	CbGbCtD
Nortriptyline—CHRM2—Pilocarpine—glaucoma	0.0239	0.0559	CbGbCtD
Nortriptyline—ADRA1A—Dipivefrin—glaucoma	0.0236	0.0553	CbGbCtD
Nortriptyline—ADRA1D—Clonidine—glaucoma	0.0214	0.05	CbGbCtD
Nortriptyline—CYP2E1—Pilocarpine—glaucoma	0.0183	0.0428	CbGbCtD
Nortriptyline—ADRA1B—Clonidine—glaucoma	0.0156	0.0364	CbGbCtD
Nortriptyline—SLC6A2—Clonidine—glaucoma	0.0142	0.0332	CbGbCtD
Nortriptyline—CYP2E1—Methazolamide—glaucoma	0.0124	0.0289	CbGbCtD
Nortriptyline—ADRA1A—Clonidine—glaucoma	0.0123	0.0287	CbGbCtD
Nortriptyline—CYP2D6—Carteolol—glaucoma	0.0115	0.0269	CbGbCtD
Nortriptyline—CYP1A2—Betaxolol—glaucoma	0.00943	0.0221	CbGbCtD
Nortriptyline—CYP2D6—Betaxolol—glaucoma	0.00777	0.0182	CbGbCtD
Nortriptyline—CYP2C19—Methazolamide—glaucoma	0.00775	0.0181	CbGbCtD
Nortriptyline—CYP2C9—Diclofenamide—glaucoma	0.00748	0.0175	CbGbCtD
Nortriptyline—CYP2C9—Dorzolamide—glaucoma	0.00723	0.0169	CbGbCtD
Nortriptyline—CYP3A5—Clonidine—glaucoma	0.00695	0.0162	CbGbCtD
Nortriptyline—CYP2C19—Timolol—glaucoma	0.00659	0.0154	CbGbCtD
Nortriptyline—CYP2C9—Methazolamide—glaucoma	0.00644	0.0151	CbGbCtD
Nortriptyline—CYP2D6—Methazolamide—glaucoma	0.00589	0.0138	CbGbCtD
Nortriptyline—CYP3A4—Pilocarpine—glaucoma	0.00555	0.013	CbGbCtD
Nortriptyline—CYP1A2—Clonidine—glaucoma	0.00517	0.0121	CbGbCtD
Nortriptyline—CYP2D6—Timolol—glaucoma	0.00501	0.0117	CbGbCtD
Nortriptyline—CYP3A4—Brinzolamide—glaucoma	0.00435	0.0102	CbGbCtD
Nortriptyline—CYP2D6—Clonidine—glaucoma	0.00426	0.00996	CbGbCtD
Nortriptyline—CYP3A4—Dorzolamide—glaucoma	0.0042	0.00983	CbGbCtD
Nortriptyline—CYP3A4—Methazolamide—glaucoma	0.00375	0.00876	CbGbCtD
Nortriptyline—CYP3A4—Acetazolamide—glaucoma	0.00299	0.007	CbGbCtD
Nortriptyline—CYP3A4—Clonidine—glaucoma	0.00271	0.00633	CbGbCtD
Nortriptyline—Amitriptyline—NTRK2—glaucoma	0.000406	0.618	CrCbGaD
Nortriptyline—Amitriptyline—NTRK1—glaucoma	0.000251	0.382	CrCbGaD
Nortriptyline—Somnolence—Brimonidine—glaucoma	0.000117	0.000901	CcSEcCtD
Nortriptyline—Hypotension—Travoprost—glaucoma	0.000117	0.0009	CcSEcCtD
Nortriptyline—Shock—Pilocarpine—glaucoma	0.000117	0.0009	CcSEcCtD
Nortriptyline—Thrombocytopenia—Pilocarpine—glaucoma	0.000116	0.000895	CcSEcCtD
Nortriptyline—Tachycardia—Pilocarpine—glaucoma	0.000116	0.000892	CcSEcCtD
Nortriptyline—Dyspepsia—Brimonidine—glaucoma	0.000116	0.000892	CcSEcCtD
Nortriptyline—Hypoaesthesia—Betaxolol—glaucoma	0.000116	0.00089	CcSEcCtD
Nortriptyline—Hallucination—Betaxolol—glaucoma	0.000116	0.00089	CcSEcCtD
Nortriptyline—Hypotension—Brinzolamide—glaucoma	0.000116	0.000889	CcSEcCtD
Nortriptyline—Hyperhidrosis—Pilocarpine—glaucoma	0.000115	0.000884	CcSEcCtD
Nortriptyline—Tension—Clonidine—glaucoma	0.000114	0.000878	CcSEcCtD
Nortriptyline—Insomnia—Dorzolamide—glaucoma	0.000114	0.000875	CcSEcCtD
Nortriptyline—Fatigue—Brimonidine—glaucoma	0.000114	0.000874	CcSEcCtD
Nortriptyline—Anorexia—Pilocarpine—glaucoma	0.000113	0.000872	CcSEcCtD
Nortriptyline—Feeling abnormal—Acetazolamide—glaucoma	0.000113	0.00087	CcSEcCtD
Nortriptyline—Hypersensitivity—Apraclonidine—glaucoma	0.000113	0.00087	CcSEcCtD
Nortriptyline—Nervousness—Clonidine—glaucoma	0.000113	0.000869	CcSEcCtD
Nortriptyline—Paraesthesia—Dorzolamide—glaucoma	0.000113	0.000869	CcSEcCtD
Nortriptyline—Insomnia—Brinzolamide—glaucoma	0.000112	0.00086	CcSEcCtD
Nortriptyline—Somnolence—Dorzolamide—glaucoma	0.000112	0.00086	CcSEcCtD
Nortriptyline—Hypotension—Pilocarpine—glaucoma	0.000111	0.000854	CcSEcCtD
Nortriptyline—Paraesthesia—Brinzolamide—glaucoma	0.000111	0.000854	CcSEcCtD
Nortriptyline—Dyspepsia—Dorzolamide—glaucoma	0.000111	0.000852	CcSEcCtD
Nortriptyline—Dyspepsia—Travoprost—glaucoma	0.00011	0.000848	CcSEcCtD
Nortriptyline—Asthenia—Apraclonidine—glaucoma	0.00011	0.000847	CcSEcCtD
Nortriptyline—Somnolence—Brinzolamide—glaucoma	0.00011	0.000846	CcSEcCtD
Nortriptyline—Vision blurred—Clonidine—glaucoma	0.00011	0.000843	CcSEcCtD
Nortriptyline—Decreased appetite—Dorzolamide—glaucoma	0.000109	0.000841	CcSEcCtD
Nortriptyline—Erectile dysfunction—Timolol—glaucoma	0.000109	0.000841	CcSEcCtD
Nortriptyline—Urticaria—Acetazolamide—glaucoma	0.000109	0.000839	CcSEcCtD
Nortriptyline—Tremor—Clonidine—glaucoma	0.000109	0.000838	CcSEcCtD
Nortriptyline—Dyspepsia—Brinzolamide—glaucoma	0.000109	0.000837	CcSEcCtD
Nortriptyline—Eye disorder—Betaxolol—glaucoma	0.000109	0.000836	CcSEcCtD
Nortriptyline—Pruritus—Apraclonidine—glaucoma	0.000108	0.000835	CcSEcCtD
Nortriptyline—Body temperature increased—Acetazolamide—glaucoma	0.000108	0.000835	CcSEcCtD
Nortriptyline—Fatigue—Dorzolamide—glaucoma	0.000108	0.000834	CcSEcCtD
Nortriptyline—Tinnitus—Betaxolol—glaucoma	0.000108	0.000834	CcSEcCtD
Nortriptyline—Fatigue—Travoprost—glaucoma	0.000108	0.000831	CcSEcCtD
Nortriptyline—Flushing—Betaxolol—glaucoma	0.000108	0.00083	CcSEcCtD
Nortriptyline—Ill-defined disorder—Clonidine—glaucoma	0.000108	0.00083	CcSEcCtD
Nortriptyline—Insomnia—Pilocarpine—glaucoma	0.000107	0.000827	CcSEcCtD
Nortriptyline—Decreased appetite—Brinzolamide—glaucoma	0.000107	0.000827	CcSEcCtD
Nortriptyline—Weight decreased—Timolol—glaucoma	0.000107	0.000826	CcSEcCtD
Nortriptyline—Constipation—Travoprost—glaucoma	0.000107	0.000824	CcSEcCtD
Nortriptyline—Agitation—Clonidine—glaucoma	0.000107	0.000822	CcSEcCtD
Nortriptyline—Paraesthesia—Pilocarpine—glaucoma	0.000107	0.000821	CcSEcCtD
Nortriptyline—Asthenia—Bimatoprost—glaucoma	0.000107	0.000821	CcSEcCtD
Nortriptyline—Fatigue—Brinzolamide—glaucoma	0.000107	0.00082	CcSEcCtD
Nortriptyline—Somnolence—Pilocarpine—glaucoma	0.000106	0.000813	CcSEcCtD
Nortriptyline—Pruritus—Bimatoprost—glaucoma	0.000105	0.00081	CcSEcCtD
Nortriptyline—Diarrhoea—Apraclonidine—glaucoma	0.000105	0.000808	CcSEcCtD
Nortriptyline—Malaise—Clonidine—glaucoma	0.000105	0.000807	CcSEcCtD
Nortriptyline—Dyspepsia—Pilocarpine—glaucoma	0.000105	0.000805	CcSEcCtD
Nortriptyline—Syncope—Clonidine—glaucoma	0.000104	0.000802	CcSEcCtD
Nortriptyline—Arrhythmia—Betaxolol—glaucoma	0.000104	0.000799	CcSEcCtD
Nortriptyline—Feeling abnormal—Dorzolamide—glaucoma	0.000104	0.000797	CcSEcCtD
Nortriptyline—Decreased appetite—Pilocarpine—glaucoma	0.000103	0.000795	CcSEcCtD
Nortriptyline—Feeling abnormal—Travoprost—glaucoma	0.000103	0.000794	CcSEcCtD
Nortriptyline—Alopecia—Betaxolol—glaucoma	0.000103	0.000791	CcSEcCtD
Nortriptyline—Palpitations—Clonidine—glaucoma	0.000103	0.000791	CcSEcCtD
Nortriptyline—Loss of consciousness—Clonidine—glaucoma	0.000102	0.000786	CcSEcCtD
Nortriptyline—Feeling abnormal—Brinzolamide—glaucoma	0.000102	0.000784	CcSEcCtD
Nortriptyline—Constipation—Pilocarpine—glaucoma	0.000102	0.000782	CcSEcCtD
Nortriptyline—Sweating—Timolol—glaucoma	0.000101	0.000781	CcSEcCtD
Nortriptyline—Dizziness—Apraclonidine—glaucoma	0.000101	0.000781	CcSEcCtD
Nortriptyline—Urticaria—Dorzolamide—glaucoma	9.99e-05	0.000769	CcSEcCtD
Nortriptyline—Body temperature increased—Dorzolamide—glaucoma	9.94e-05	0.000765	CcSEcCtD
Nortriptyline—Abdominal pain—Dorzolamide—glaucoma	9.94e-05	0.000765	CcSEcCtD
Nortriptyline—Tension—Betaxolol—glaucoma	9.93e-05	0.000764	CcSEcCtD
Nortriptyline—Dysgeusia—Betaxolol—glaucoma	9.91e-05	0.000763	CcSEcCtD
Nortriptyline—Abdominal pain—Travoprost—glaucoma	9.9e-05	0.000762	CcSEcCtD
Nortriptyline—Agranulocytosis—Timolol—glaucoma	9.87e-05	0.00076	CcSEcCtD
Nortriptyline—Anxiety—Clonidine—glaucoma	9.86e-05	0.000759	CcSEcCtD
Nortriptyline—Asthenia—Acetazolamide—glaucoma	9.84e-05	0.000757	CcSEcCtD
Nortriptyline—Dizziness—Bimatoprost—glaucoma	9.83e-05	0.000757	CcSEcCtD
Nortriptyline—Nervousness—Betaxolol—glaucoma	9.83e-05	0.000757	CcSEcCtD
Nortriptyline—Urticaria—Brinzolamide—glaucoma	9.82e-05	0.000756	CcSEcCtD
Nortriptyline—Feeling abnormal—Pilocarpine—glaucoma	9.79e-05	0.000754	CcSEcCtD
Nortriptyline—Discomfort—Clonidine—glaucoma	9.78e-05	0.000753	CcSEcCtD
Nortriptyline—Vomiting—Apraclonidine—glaucoma	9.75e-05	0.00075	CcSEcCtD
Nortriptyline—Hypersensitivity—Brimonidine—glaucoma	9.7e-05	0.000747	CcSEcCtD
Nortriptyline—Dry mouth—Clonidine—glaucoma	9.68e-05	0.000745	CcSEcCtD
Nortriptyline—Dermatitis—Apraclonidine—glaucoma	9.66e-05	0.000744	CcSEcCtD
Nortriptyline—Headache—Apraclonidine—glaucoma	9.61e-05	0.000739	CcSEcCtD
Nortriptyline—Confusional state—Clonidine—glaucoma	9.57e-05	0.000736	CcSEcCtD
Nortriptyline—Vision blurred—Betaxolol—glaucoma	9.54e-05	0.000734	CcSEcCtD
Nortriptyline—Oedema—Clonidine—glaucoma	9.49e-05	0.00073	CcSEcCtD
Nortriptyline—Tremor—Betaxolol—glaucoma	9.48e-05	0.00073	CcSEcCtD
Nortriptyline—Hallucination—Timolol—glaucoma	9.45e-05	0.000727	CcSEcCtD
Nortriptyline—Asthenia—Brimonidine—glaucoma	9.45e-05	0.000727	CcSEcCtD
Nortriptyline—Abdominal pain—Pilocarpine—glaucoma	9.39e-05	0.000723	CcSEcCtD
Nortriptyline—Body temperature increased—Pilocarpine—glaucoma	9.39e-05	0.000723	CcSEcCtD
Nortriptyline—Ill-defined disorder—Betaxolol—glaucoma	9.39e-05	0.000723	CcSEcCtD
Nortriptyline—Diarrhoea—Acetazolamide—glaucoma	9.39e-05	0.000722	CcSEcCtD
Nortriptyline—Rash—Bimatoprost—glaucoma	9.37e-05	0.000722	CcSEcCtD
Nortriptyline—Dermatitis—Bimatoprost—glaucoma	9.37e-05	0.000721	CcSEcCtD
Nortriptyline—Oedema peripheral—Timolol—glaucoma	9.36e-05	0.00072	CcSEcCtD
Nortriptyline—Shock—Clonidine—glaucoma	9.33e-05	0.000718	CcSEcCtD
Nortriptyline—Pruritus—Brimonidine—glaucoma	9.31e-05	0.000717	CcSEcCtD
Nortriptyline—Headache—Bimatoprost—glaucoma	9.31e-05	0.000717	CcSEcCtD
Nortriptyline—Thrombocytopenia—Clonidine—glaucoma	9.29e-05	0.000715	CcSEcCtD
Nortriptyline—Hypersensitivity—Dorzolamide—glaucoma	9.26e-05	0.000713	CcSEcCtD
Nortriptyline—Tachycardia—Clonidine—glaucoma	9.26e-05	0.000713	CcSEcCtD
Nortriptyline—Hypersensitivity—Travoprost—glaucoma	9.22e-05	0.00071	CcSEcCtD
Nortriptyline—Hyperhidrosis—Clonidine—glaucoma	9.17e-05	0.000706	CcSEcCtD
Nortriptyline—Malaise—Betaxolol—glaucoma	9.13e-05	0.000702	CcSEcCtD
Nortriptyline—Nausea—Apraclonidine—glaucoma	9.11e-05	0.000701	CcSEcCtD
Nortriptyline—Hypersensitivity—Brinzolamide—glaucoma	9.11e-05	0.000701	CcSEcCtD
Nortriptyline—Syncope—Betaxolol—glaucoma	9.08e-05	0.000699	CcSEcCtD
Nortriptyline—Dizziness—Acetazolamide—glaucoma	9.07e-05	0.000698	CcSEcCtD
Nortriptyline—Anorexia—Clonidine—glaucoma	9.04e-05	0.000696	CcSEcCtD
Nortriptyline—Asthenia—Dorzolamide—glaucoma	9.02e-05	0.000694	CcSEcCtD
Nortriptyline—Asthenia—Travoprost—glaucoma	8.98e-05	0.000691	CcSEcCtD
Nortriptyline—Palpitations—Betaxolol—glaucoma	8.94e-05	0.000688	CcSEcCtD
Nortriptyline—Pruritus—Dorzolamide—glaucoma	8.9e-05	0.000685	CcSEcCtD
Nortriptyline—Loss of consciousness—Betaxolol—glaucoma	8.9e-05	0.000685	CcSEcCtD
Nortriptyline—Eye disorder—Timolol—glaucoma	8.88e-05	0.000683	CcSEcCtD
Nortriptyline—Asthenia—Brinzolamide—glaucoma	8.87e-05	0.000683	CcSEcCtD
Nortriptyline—Hypotension—Clonidine—glaucoma	8.87e-05	0.000682	CcSEcCtD
Nortriptyline—Pruritus—Travoprost—glaucoma	8.86e-05	0.000682	CcSEcCtD
Nortriptyline—Tinnitus—Timolol—glaucoma	8.86e-05	0.000682	CcSEcCtD
Nortriptyline—Nausea—Bimatoprost—glaucoma	8.83e-05	0.00068	CcSEcCtD
Nortriptyline—Hypersensitivity—Pilocarpine—glaucoma	8.75e-05	0.000674	CcSEcCtD
Nortriptyline—Pruritus—Brinzolamide—glaucoma	8.75e-05	0.000673	CcSEcCtD
Nortriptyline—Vomiting—Acetazolamide—glaucoma	8.72e-05	0.000671	CcSEcCtD
Nortriptyline—Dizziness—Brimonidine—glaucoma	8.71e-05	0.00067	CcSEcCtD
Nortriptyline—Diarrhoea—Dorzolamide—glaucoma	8.6e-05	0.000662	CcSEcCtD
Nortriptyline—Headache—Acetazolamide—glaucoma	8.59e-05	0.000661	CcSEcCtD
Nortriptyline—Anxiety—Betaxolol—glaucoma	8.59e-05	0.000661	CcSEcCtD
Nortriptyline—Insomnia—Clonidine—glaucoma	8.58e-05	0.00066	CcSEcCtD
Nortriptyline—Diarrhoea—Travoprost—glaucoma	8.57e-05	0.000659	CcSEcCtD
Nortriptyline—Asthenia—Pilocarpine—glaucoma	8.52e-05	0.000656	CcSEcCtD
Nortriptyline—Paraesthesia—Clonidine—glaucoma	8.52e-05	0.000656	CcSEcCtD
Nortriptyline—Discomfort—Betaxolol—glaucoma	8.51e-05	0.000655	CcSEcCtD
Nortriptyline—Arrhythmia—Timolol—glaucoma	8.48e-05	0.000653	CcSEcCtD
Nortriptyline—Diarrhoea—Brinzolamide—glaucoma	8.46e-05	0.000651	CcSEcCtD
Nortriptyline—Somnolence—Clonidine—glaucoma	8.43e-05	0.000649	CcSEcCtD
Nortriptyline—Dry mouth—Betaxolol—glaucoma	8.43e-05	0.000649	CcSEcCtD
Nortriptyline—Pruritus—Pilocarpine—glaucoma	8.41e-05	0.000647	CcSEcCtD
Nortriptyline—Alopecia—Timolol—glaucoma	8.39e-05	0.000646	CcSEcCtD
Nortriptyline—Confusional state—Betaxolol—glaucoma	8.33e-05	0.000641	CcSEcCtD
Nortriptyline—Dizziness—Dorzolamide—glaucoma	8.31e-05	0.00064	CcSEcCtD
Nortriptyline—Rash—Brimonidine—glaucoma	8.3e-05	0.000639	CcSEcCtD
Nortriptyline—Dermatitis—Brimonidine—glaucoma	8.29e-05	0.000638	CcSEcCtD
Nortriptyline—Dizziness—Travoprost—glaucoma	8.28e-05	0.000637	CcSEcCtD
Nortriptyline—Oedema—Betaxolol—glaucoma	8.26e-05	0.000636	CcSEcCtD
Nortriptyline—Headache—Brimonidine—glaucoma	8.25e-05	0.000635	CcSEcCtD
Nortriptyline—Decreased appetite—Clonidine—glaucoma	8.25e-05	0.000635	CcSEcCtD
Nortriptyline—Fatigue—Clonidine—glaucoma	8.18e-05	0.00063	CcSEcCtD
Nortriptyline—Dizziness—Brinzolamide—glaucoma	8.17e-05	0.000629	CcSEcCtD
Nortriptyline—Nausea—Acetazolamide—glaucoma	8.15e-05	0.000627	CcSEcCtD
Nortriptyline—Diarrhoea—Pilocarpine—glaucoma	8.13e-05	0.000626	CcSEcCtD
Nortriptyline—Shock—Betaxolol—glaucoma	8.13e-05	0.000625	CcSEcCtD
Nortriptyline—Tension—Timolol—glaucoma	8.11e-05	0.000624	CcSEcCtD
Nortriptyline—Constipation—Clonidine—glaucoma	8.11e-05	0.000624	CcSEcCtD
Nortriptyline—Dysgeusia—Timolol—glaucoma	8.1e-05	0.000623	CcSEcCtD
Nortriptyline—Thrombocytopenia—Betaxolol—glaucoma	8.09e-05	0.000622	CcSEcCtD
Nortriptyline—Tachycardia—Betaxolol—glaucoma	8.06e-05	0.00062	CcSEcCtD
Nortriptyline—Nervousness—Timolol—glaucoma	8.03e-05	0.000618	CcSEcCtD
Nortriptyline—Vomiting—Dorzolamide—glaucoma	7.99e-05	0.000615	CcSEcCtD
Nortriptyline—Hyperhidrosis—Betaxolol—glaucoma	7.99e-05	0.000615	CcSEcCtD
Nortriptyline—Rash—Dorzolamide—glaucoma	7.93e-05	0.00061	CcSEcCtD
Nortriptyline—Dermatitis—Dorzolamide—glaucoma	7.92e-05	0.00061	CcSEcCtD
Nortriptyline—Rash—Travoprost—glaucoma	7.89e-05	0.000608	CcSEcCtD
Nortriptyline—Dermatitis—Travoprost—glaucoma	7.89e-05	0.000607	CcSEcCtD
Nortriptyline—Headache—Dorzolamide—glaucoma	7.88e-05	0.000606	CcSEcCtD
Nortriptyline—Anorexia—Betaxolol—glaucoma	7.87e-05	0.000606	CcSEcCtD
Nortriptyline—Vomiting—Brinzolamide—glaucoma	7.86e-05	0.000605	CcSEcCtD
Nortriptyline—Dizziness—Pilocarpine—glaucoma	7.86e-05	0.000605	CcSEcCtD
Nortriptyline—Headache—Travoprost—glaucoma	7.84e-05	0.000604	CcSEcCtD
Nortriptyline—Nausea—Brimonidine—glaucoma	7.82e-05	0.000602	CcSEcCtD
Nortriptyline—Feeling abnormal—Clonidine—glaucoma	7.82e-05	0.000602	CcSEcCtD
Nortriptyline—Rash—Brinzolamide—glaucoma	7.79e-05	0.0006	CcSEcCtD
Nortriptyline—Vision blurred—Timolol—glaucoma	7.79e-05	0.0006	CcSEcCtD
Nortriptyline—Dermatitis—Brinzolamide—glaucoma	7.79e-05	0.000599	CcSEcCtD
Nortriptyline—Headache—Brinzolamide—glaucoma	7.74e-05	0.000596	CcSEcCtD
Nortriptyline—Hypotension—Betaxolol—glaucoma	7.72e-05	0.000594	CcSEcCtD
Nortriptyline—Vomiting—Pilocarpine—glaucoma	7.55e-05	0.000581	CcSEcCtD
Nortriptyline—Urticaria—Clonidine—glaucoma	7.54e-05	0.00058	CcSEcCtD
Nortriptyline—Abdominal pain—Clonidine—glaucoma	7.5e-05	0.000577	CcSEcCtD
Nortriptyline—Body temperature increased—Clonidine—glaucoma	7.5e-05	0.000577	CcSEcCtD
Nortriptyline—Rash—Pilocarpine—glaucoma	7.49e-05	0.000577	CcSEcCtD
Nortriptyline—Dermatitis—Pilocarpine—glaucoma	7.48e-05	0.000576	CcSEcCtD
Nortriptyline—Insomnia—Betaxolol—glaucoma	7.47e-05	0.000575	CcSEcCtD
Nortriptyline—Nausea—Dorzolamide—glaucoma	7.47e-05	0.000575	CcSEcCtD
Nortriptyline—Headache—Pilocarpine—glaucoma	7.44e-05	0.000573	CcSEcCtD
Nortriptyline—Nausea—Travoprost—glaucoma	7.44e-05	0.000572	CcSEcCtD
Nortriptyline—Paraesthesia—Betaxolol—glaucoma	7.42e-05	0.000571	CcSEcCtD
Nortriptyline—Syncope—Timolol—glaucoma	7.41e-05	0.000571	CcSEcCtD
Nortriptyline—Nausea—Brinzolamide—glaucoma	7.34e-05	0.000565	CcSEcCtD
Nortriptyline—Palpitations—Timolol—glaucoma	7.31e-05	0.000562	CcSEcCtD
Nortriptyline—Dyspepsia—Betaxolol—glaucoma	7.27e-05	0.00056	CcSEcCtD
Nortriptyline—Loss of consciousness—Timolol—glaucoma	7.27e-05	0.000559	CcSEcCtD
Nortriptyline—Decreased appetite—Betaxolol—glaucoma	7.18e-05	0.000553	CcSEcCtD
Nortriptyline—Hypertension—Timolol—glaucoma	7.14e-05	0.000549	CcSEcCtD
Nortriptyline—Fatigue—Betaxolol—glaucoma	7.12e-05	0.000548	CcSEcCtD
Nortriptyline—Constipation—Betaxolol—glaucoma	7.06e-05	0.000544	CcSEcCtD
Nortriptyline—Nausea—Pilocarpine—glaucoma	7.06e-05	0.000543	CcSEcCtD
Nortriptyline—Anxiety—Timolol—glaucoma	7.01e-05	0.00054	CcSEcCtD
Nortriptyline—Hypersensitivity—Clonidine—glaucoma	6.99e-05	0.000538	CcSEcCtD
Nortriptyline—Discomfort—Timolol—glaucoma	6.95e-05	0.000535	CcSEcCtD
Nortriptyline—Dry mouth—Timolol—glaucoma	6.88e-05	0.00053	CcSEcCtD
Nortriptyline—Asthenia—Clonidine—glaucoma	6.81e-05	0.000524	CcSEcCtD
Nortriptyline—Feeling abnormal—Betaxolol—glaucoma	6.81e-05	0.000524	CcSEcCtD
Nortriptyline—Confusional state—Timolol—glaucoma	6.8e-05	0.000524	CcSEcCtD
Nortriptyline—Oedema—Timolol—glaucoma	6.75e-05	0.000519	CcSEcCtD
Nortriptyline—Pruritus—Clonidine—glaucoma	6.71e-05	0.000517	CcSEcCtD
Nortriptyline—Shock—Timolol—glaucoma	6.64e-05	0.000511	CcSEcCtD
Nortriptyline—Urticaria—Betaxolol—glaucoma	6.56e-05	0.000505	CcSEcCtD
Nortriptyline—Body temperature increased—Betaxolol—glaucoma	6.53e-05	0.000503	CcSEcCtD
Nortriptyline—Hyperhidrosis—Timolol—glaucoma	6.52e-05	0.000502	CcSEcCtD
Nortriptyline—Diarrhoea—Clonidine—glaucoma	6.49e-05	0.0005	CcSEcCtD
Nortriptyline—Anorexia—Timolol—glaucoma	6.43e-05	0.000495	CcSEcCtD
Nortriptyline—Hypotension—Timolol—glaucoma	6.31e-05	0.000485	CcSEcCtD
Nortriptyline—Dizziness—Clonidine—glaucoma	6.27e-05	0.000483	CcSEcCtD
Nortriptyline—Insomnia—Timolol—glaucoma	6.1e-05	0.00047	CcSEcCtD
Nortriptyline—Hypersensitivity—Betaxolol—glaucoma	6.09e-05	0.000468	CcSEcCtD
Nortriptyline—Paraesthesia—Timolol—glaucoma	6.06e-05	0.000466	CcSEcCtD
Nortriptyline—Vomiting—Clonidine—glaucoma	6.03e-05	0.000464	CcSEcCtD
Nortriptyline—Somnolence—Timolol—glaucoma	6e-05	0.000462	CcSEcCtD
Nortriptyline—Rash—Clonidine—glaucoma	5.98e-05	0.00046	CcSEcCtD
Nortriptyline—Dermatitis—Clonidine—glaucoma	5.98e-05	0.00046	CcSEcCtD
Nortriptyline—Headache—Clonidine—glaucoma	5.94e-05	0.000457	CcSEcCtD
Nortriptyline—Dyspepsia—Timolol—glaucoma	5.94e-05	0.000457	CcSEcCtD
Nortriptyline—Asthenia—Betaxolol—glaucoma	5.93e-05	0.000456	CcSEcCtD
Nortriptyline—Decreased appetite—Timolol—glaucoma	5.87e-05	0.000451	CcSEcCtD
Nortriptyline—Pruritus—Betaxolol—glaucoma	5.84e-05	0.00045	CcSEcCtD
Nortriptyline—Fatigue—Timolol—glaucoma	5.82e-05	0.000448	CcSEcCtD
Nortriptyline—Diarrhoea—Betaxolol—glaucoma	5.65e-05	0.000435	CcSEcCtD
Nortriptyline—Nausea—Clonidine—glaucoma	5.64e-05	0.000434	CcSEcCtD
Nortriptyline—Feeling abnormal—Timolol—glaucoma	5.56e-05	0.000428	CcSEcCtD
Nortriptyline—Dizziness—Betaxolol—glaucoma	5.46e-05	0.00042	CcSEcCtD
Nortriptyline—Urticaria—Timolol—glaucoma	5.36e-05	0.000413	CcSEcCtD
Nortriptyline—Body temperature increased—Timolol—glaucoma	5.33e-05	0.000411	CcSEcCtD
Nortriptyline—Abdominal pain—Timolol—glaucoma	5.33e-05	0.000411	CcSEcCtD
Nortriptyline—Vomiting—Betaxolol—glaucoma	5.25e-05	0.000404	CcSEcCtD
Nortriptyline—Rash—Betaxolol—glaucoma	5.21e-05	0.000401	CcSEcCtD
Nortriptyline—Dermatitis—Betaxolol—glaucoma	5.2e-05	0.0004	CcSEcCtD
Nortriptyline—Headache—Betaxolol—glaucoma	5.17e-05	0.000398	CcSEcCtD
Nortriptyline—Hypersensitivity—Timolol—glaucoma	4.97e-05	0.000383	CcSEcCtD
Nortriptyline—Nausea—Betaxolol—glaucoma	4.91e-05	0.000378	CcSEcCtD
Nortriptyline—Asthenia—Timolol—glaucoma	4.84e-05	0.000373	CcSEcCtD
Nortriptyline—Pruritus—Timolol—glaucoma	4.77e-05	0.000367	CcSEcCtD
Nortriptyline—Diarrhoea—Timolol—glaucoma	4.62e-05	0.000355	CcSEcCtD
Nortriptyline—Dizziness—Timolol—glaucoma	4.46e-05	0.000343	CcSEcCtD
Nortriptyline—Vomiting—Timolol—glaucoma	4.29e-05	0.00033	CcSEcCtD
Nortriptyline—Rash—Timolol—glaucoma	4.25e-05	0.000327	CcSEcCtD
Nortriptyline—Dermatitis—Timolol—glaucoma	4.25e-05	0.000327	CcSEcCtD
Nortriptyline—Headache—Timolol—glaucoma	4.23e-05	0.000325	CcSEcCtD
Nortriptyline—Nausea—Timolol—glaucoma	4.01e-05	0.000308	CcSEcCtD
Nortriptyline—PTGS1—Metabolism—MTHFR—glaucoma	4.96e-06	0.000122	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NGFR—glaucoma	4.95e-06	0.000122	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—C3—glaucoma	4.93e-06	0.000122	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EDN1—glaucoma	4.91e-06	0.000121	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EDN1—glaucoma	4.89e-06	0.000121	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NTRK1—glaucoma	4.88e-06	0.000121	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—APOE—glaucoma	4.88e-06	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	4.88e-06	0.00012	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CAV1—glaucoma	4.83e-06	0.000119	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—FN1—glaucoma	4.8e-06	0.000119	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NTRK1—glaucoma	4.8e-06	0.000119	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NTRK1—glaucoma	4.79e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NTRK1—glaucoma	4.78e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NTRK1—glaucoma	4.76e-06	0.000118	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—BAD—glaucoma	4.75e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NTRK1—glaucoma	4.71e-06	0.000116	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NTRK1—glaucoma	4.7e-06	0.000116	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EDN1—glaucoma	4.68e-06	0.000116	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTT1—glaucoma	4.67e-06	0.000115	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.66e-06	0.000115	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTT1—glaucoma	4.63e-06	0.000114	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—APOE—glaucoma	4.62e-06	0.000114	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.61e-06	0.000114	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—FN1—glaucoma	4.6e-06	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—APOE—glaucoma	4.59e-06	0.000113	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CAV1—glaucoma	4.57e-06	0.000113	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.56e-06	0.000113	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—BAD—glaucoma	4.55e-06	0.000112	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CAV1—glaucoma	4.54e-06	0.000112	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NGF—glaucoma	4.52e-06	0.000112	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP1B1—glaucoma	4.51e-06	0.000111	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ABCA1—glaucoma	4.51e-06	0.000111	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN2B—glaucoma	4.5e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NGF—glaucoma	4.49e-06	0.000111	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN2B—glaucoma	4.43e-06	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN2B—glaucoma	4.42e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN2B—glaucoma	4.4e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MTHFR—glaucoma	4.4e-06	0.000109	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN2B—glaucoma	4.39e-06	0.000108	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN2B—glaucoma	4.34e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	4.33e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—FN1—glaucoma	4.33e-06	0.000107	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EDN1—glaucoma	4.32e-06	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NGF—glaucoma	4.3e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—C3—glaucoma	4.29e-06	0.000106	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—BAD—glaucoma	4.27e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—C3—glaucoma	4.27e-06	0.000106	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EDN1—glaucoma	4.25e-06	0.000105	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EDN1—glaucoma	4.24e-06	0.000105	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EDN1—glaucoma	4.22e-06	0.000104	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EDN1—glaucoma	4.21e-06	0.000104	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTM1—glaucoma	4.19e-06	0.000104	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTM1—glaucoma	4.18e-06	0.000103	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EDN1—glaucoma	4.17e-06	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EDN1—glaucoma	4.16e-06	0.000103	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.1e-06	0.000101	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—APOE—glaucoma	4.09e-06	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—C3—glaucoma	4.09e-06	0.000101	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CAV1—glaucoma	4.06e-06	0.0001	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ABCA1—glaucoma	4.05e-06	0.0001	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP1B1—glaucoma	4.05e-06	0.0001	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NOS3—glaucoma	4.05e-06	9.99e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—APOE—glaucoma	4e-06	9.87e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—APOE—glaucoma	3.98e-06	9.82e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NGF—glaucoma	3.97e-06	9.79e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CAV1—glaucoma	3.96e-06	9.78e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTT1—glaucoma	3.96e-06	9.78e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—VEGFA—glaucoma	3.95e-06	9.75e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CAV1—glaucoma	3.94e-06	9.73e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TXN—glaucoma	3.94e-06	9.73e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NGF—glaucoma	3.9e-06	9.64e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NGF—glaucoma	3.89e-06	9.62e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NGF—glaucoma	3.88e-06	9.59e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NGF—glaucoma	3.87e-06	9.56e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NGF—glaucoma	3.83e-06	9.46e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NGF—glaucoma	3.82e-06	9.44e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NOS3—glaucoma	3.82e-06	9.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—APOE—glaucoma	3.81e-06	9.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CAV1—glaucoma	3.77e-06	9.32e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—C3—glaucoma	3.77e-06	9.31e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—FN1—glaucoma	3.77e-06	9.31e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—FN1—glaucoma	3.75e-06	9.26e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.73e-06	9.22e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—BAD—glaucoma	3.72e-06	9.2e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP1B1—glaucoma	3.72e-06	9.19e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ABCA1—glaucoma	3.72e-06	9.19e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—C3—glaucoma	3.71e-06	9.16e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—glaucoma	3.71e-06	9.15e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—BAD—glaucoma	3.71e-06	9.15e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—C3—glaucoma	3.7e-06	9.14e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—glaucoma	3.7e-06	9.14e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP1B1—glaucoma	3.69e-06	9.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ABCA1—glaucoma	3.69e-06	9.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—C3—glaucoma	3.69e-06	9.11e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—C3—glaucoma	3.68e-06	9.08e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NOS3—glaucoma	3.65e-06	9.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—C3—glaucoma	3.64e-06	9e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—C3—glaucoma	3.63e-06	8.97e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTM1—glaucoma	3.6e-06	8.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—FN1—glaucoma	3.59e-06	8.87e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—BAD—glaucoma	3.55e-06	8.76e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—APOE—glaucoma	3.51e-06	8.67e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CDKN1B—glaucoma	3.5e-06	8.66e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CAV1—glaucoma	3.48e-06	8.59e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—NOS3—glaucoma	3.46e-06	8.54e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—APOE—glaucoma	3.45e-06	8.53e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—APOE—glaucoma	3.45e-06	8.52e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—APOE—glaucoma	3.45e-06	8.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—APOE—glaucoma	3.44e-06	8.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NOS3—glaucoma	3.44e-06	8.49e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—APOE—glaucoma	3.43e-06	8.48e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—APOE—glaucoma	3.42e-06	8.46e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CAV1—glaucoma	3.42e-06	8.45e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CAV1—glaucoma	3.42e-06	8.44e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CAV1—glaucoma	3.41e-06	8.43e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CAV1—glaucoma	3.41e-06	8.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CAV1—glaucoma	3.4e-06	8.41e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CAV1—glaucoma	3.39e-06	8.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—APOE—glaucoma	3.39e-06	8.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—APOE—glaucoma	3.38e-06	8.35e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CAV1—glaucoma	3.36e-06	8.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CAV1—glaucoma	3.35e-06	8.27e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—FN1—glaucoma	3.31e-06	8.17e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CDKN1B—glaucoma	3.31e-06	8.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—BAD—glaucoma	3.27e-06	8.08e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—FN1—glaucoma	3.26e-06	8.04e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—FN1—glaucoma	3.25e-06	8.03e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—glaucoma	3.25e-06	8.02e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—FN1—glaucoma	3.24e-06	8e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTM1—glaucoma	3.24e-06	7.99e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—FN1—glaucoma	3.23e-06	7.98e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—BAD—glaucoma	3.22e-06	7.95e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—BAD—glaucoma	3.21e-06	7.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—BAD—glaucoma	3.2e-06	7.91e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—FN1—glaucoma	3.2e-06	7.9e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.19e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—BAD—glaucoma	3.19e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—FN1—glaucoma	3.19e-06	7.88e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—glaucoma	3.19e-06	7.87e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CDKN1B—glaucoma	3.17e-06	7.82e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—glaucoma	3.16e-06	7.81e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—BAD—glaucoma	3.16e-06	7.8e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP1B1—glaucoma	3.15e-06	7.79e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ABCA1—glaucoma	3.15e-06	7.79e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—BAD—glaucoma	3.15e-06	7.78e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—NOS3—glaucoma	3.07e-06	7.58e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—glaucoma	3.06e-06	7.56e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTT1—glaucoma	3.05e-06	7.54e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOS3—glaucoma	2.99e-06	7.4e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—glaucoma	2.98e-06	7.37e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOS3—glaucoma	2.98e-06	7.36e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	2.98e-06	7.35e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTM1—glaucoma	2.98e-06	7.35e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—glaucoma	2.97e-06	7.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTM1—glaucoma	2.95e-06	7.29e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CAV1—glaucoma	2.94e-06	7.26e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—glaucoma	2.93e-06	7.24e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—VEGFA—glaucoma	2.91e-06	7.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—glaucoma	2.86e-06	7.06e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOS3—glaucoma	2.85e-06	7.04e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—glaucoma	2.81e-06	6.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—glaucoma	2.76e-06	6.81e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.75e-06	6.79e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—glaucoma	2.66e-06	6.57e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CAV1—glaucoma	2.64e-06	6.51e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.63e-06	6.5e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—glaucoma	2.63e-06	6.5e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—glaucoma	2.63e-06	6.49e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—glaucoma	2.61e-06	6.44e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CDKN1B—glaucoma	2.59e-06	6.41e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—glaucoma	2.59e-06	6.39e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—glaucoma	2.58e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—glaucoma	2.58e-06	6.38e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CDKN1B—glaucoma	2.58e-06	6.37e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—glaucoma	2.58e-06	6.37e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—glaucoma	2.57e-06	6.36e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—glaucoma	2.57e-06	6.34e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—glaucoma	2.54e-06	6.27e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—glaucoma	2.53e-06	6.26e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTM1—glaucoma	2.52e-06	6.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—VEGFA—glaucoma	2.48e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.47e-06	6.1e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—glaucoma	2.45e-06	6.05e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCA1—glaucoma	2.43e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CYP1B1—glaucoma	2.43e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—glaucoma	2.43e-06	6e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CAV1—glaucoma	2.43e-06	5.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CAV1—glaucoma	2.4e-06	5.94e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—glaucoma	2.4e-06	5.93e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—glaucoma	2.39e-06	5.9e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—glaucoma	2.36e-06	5.84e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—glaucoma	2.36e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.29e-06	5.65e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CDKN1B—glaucoma	2.28e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CDKN1B—glaucoma	2.24e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CDKN1B—glaucoma	2.24e-06	5.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CDKN1B—glaucoma	2.23e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—glaucoma	2.23e-06	5.5e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CDKN1B—glaucoma	2.22e-06	5.49e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—glaucoma	2.22e-06	5.49e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—glaucoma	2.2e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CDKN1B—glaucoma	2.2e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.19e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—glaucoma	2.16e-06	5.33e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—glaucoma	2.15e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—glaucoma	2.11e-06	5.21e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—glaucoma	2.08e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—glaucoma	2.08e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—glaucoma	2.07e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—glaucoma	2.07e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—glaucoma	2.06e-06	5.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—glaucoma	2.06e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CAV1—glaucoma	2.06e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.05e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—glaucoma	2.04e-06	5.03e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.03e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—glaucoma	2.03e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—glaucoma	1.99e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—glaucoma	1.99e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTM1—glaucoma	1.95e-06	4.81e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—glaucoma	1.89e-06	4.68e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—glaucoma	1.87e-06	4.62e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—glaucoma	1.86e-06	4.6e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—glaucoma	1.86e-06	4.59e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.85e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.85e-06	4.56e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—glaucoma	1.83e-06	4.53e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.83e-06	4.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.83e-06	4.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—glaucoma	1.82e-06	4.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—glaucoma	1.82e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—glaucoma	1.72e-06	4.25e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—glaucoma	1.68e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—glaucoma	1.66e-06	4.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—glaucoma	1.63e-06	4.03e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—glaucoma	1.62e-06	4.01e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—glaucoma	1.6e-06	3.95e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CAV1—glaucoma	1.59e-06	3.92e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—glaucoma	1.55e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—glaucoma	1.55e-06	3.83e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—glaucoma	1.43e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—glaucoma	1.42e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—glaucoma	1.41e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—glaucoma	1.41e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—glaucoma	1.4e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—glaucoma	1.4e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—glaucoma	1.38e-06	3.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—glaucoma	1.38e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—glaucoma	1.2e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—glaucoma	1.1e-06	2.71e-05	CbGpPWpGaD
